Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Prostaglandin D2 Synthase (PTGDS) Peptide

PTGDS Host: Synthetic BP, WB, IHC
Catalog No. ABIN8109069
$145.08
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 2 to 4 Business Days

Quick Overview for Prostaglandin D2 Synthase (PTGDS) Peptide (ABIN8109069)

Target

PTGDS (Prostaglandin D2 Synthase (PTGDS))

Source

  • 11
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Purpose

    PTGDS Peptide
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    This is a synthetic peptide designed for use in combination with anti-PTGDS antibody ( ARP48154_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Target

    PTGDS (Prostaglandin D2 Synthase (PTGDS))

    Background

    Background Information: PTGDS is a glutathione-independent prostaglandin D synthase that catalyzes the conversion of prostaglandin H2 (PGH2) to postaglandin D2 (PGD2). PGD2 functions as a neuromodulator as well as a trophic factor in the central nervous system. PGD2 is also involved in smooth muscle contraction/relaxation and is a potent inhibitor of platelet aggregation.The protein encoded by this gene is a glutathione-independent prostaglandin D synthase that catalyzes the conversion of prostaglandin H2 (PGH2) to postaglandin D2 (PGD2). PGD2 functions as a neuromodulator as well as a trophic factor in the central nervous system. PGD2 is also involved in smooth muscle contraction/relaxation and is a potent inhibitor of platelet aggregation. This gene is preferentially expressed in brain. Studies with transgenic mice overexpressing this gene suggest that this gene may be also involved in the regulation of non-rapid eye movement sleep. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

    Alternative Symbols: PDS, PGD2, PGDS, PGDS2, LPGDS, L-PGDS

    Molecular Weight

    21kDa

    Gene ID

    5730

    NCBI Accession

    NP_000945

    UniProt

    P41222
You are here:
Chat with us!